Journal of Cell Biology 'Under Review': What Each Status Means

JCB operates the in-house professional handling editor + academic editorial board collaborative model. At JCB, all editorial decisions on research manuscripts are made through collaborative consultation between in-house professional scientific editors and the academic editorial board. The in-house professional scientific editors are full-time staff who read the entire paper, while the academic editorial board (consulting editors with active research labs in cell biology) provide subspecialty expertise during the collaborative consultation. The final decision lies with the academic editors. A JCB in-house professional editor typically handles 40 to 60 manuscripts per quarter and spends 30 to 90 minutes on the initial read; academic editors at JCB are working academics fitting JCB editorial work around their own cell-biology research.

JCB editorial culture is decisive: a 3 to 4 day initial decision means scope and quality issues surface fast. Papers that pass the JCB collaborative editor screen have cleared the steepest filter in cell-biology specialty publishing.

Before the paper reaches external reviewers, a JCB in-house professional scientific editor and academic editorial board member evaluate whether the cell-biology significance warrants JCB's selective editorial slots. About 60 to 70 percent of submissions are rejected at this stage within the 3 to 4 day initial decision target. A desk rejection most often means the editors concluded that the work would fit better at a sister cell-biology journal (Molecular Biology of the Cell from ASCB, Journal of Cell Science from Company of Biologists, sister Rockefeller journals JEM and JGP) or that the cell-biology priority bar is not met. The collaborative in-house + academic model means desk-screen decisions reflect both professional editorial judgment and academic subspecialty expertise.

The JCB editorial office confirms files are complete: manuscript with figures embedded, supplementary information separate, reporting checklists where applicable (ARRIVE for animal work, MIQE for quantitative PCR), JCB DataViewer image-data documentation, cover letter directed to the editor, conflict-of-interest declarations, ethics-statement documentation, IRB approvals, and data-availability statement (JCB requires raw image data deposition to JCB DataViewer for cell-biology imaging papers).

The in-house professional scientific editor reads the paper and evaluates cell-biology significance, scientific rigor, and JCB family routing. The 3 to 4 day initial decision target reflects JCB's commitment to fast turnaround.

In parallel with the in-house professional editor's primary read, the assigned academic editor (a cell-biology consulting editor with subspecialty expertise) provides collaborative consultation on whether the paper warrants peer review. This collaborative consultation is JCB's distinctive feature: all editorial decisions are made through collaborative consultation between in-house professional scientific editors and the academic editorial board, with final decision lying with the academic editor.

JCB academic editors typically invite 2 to 3 external reviewers. In practical reviewer-count terms, that usually means two reviewers, with recruitment often taking 5 to 10 days before the reports are in motion. The manuscript is refereed by leading scientists active in the relevant field regardless of their membership on the JCB editorial board. The recruitment window can take 5 to 10 days because reviewers with topic-matched cell-biology subspecialty expertise are scarce.

Once reviewers agree to review, the typical JCB peer-review cycle lasts 3 to 8 weeks per reviewer. Reviewers are asked to evaluate cell-biology significance, scientific rigor, image-data integrity (JCB has strong image-data integrity policies), and reproducibility. Reviewer reports for JCB tend to be focused; 1500 to 3000 word reports are typical given the single-round revision policy.

After reports return, the academic editor synthesizes them in collaborative consultation with the in-house professional editor. Following review, the journal will encourage resubmission if revisions seem feasible within 3 to 4 months. JCB's policy is to only allow a single round of major revision; a decision is usually communicated to the authors within 10 days after revision submission.

• Rejection within 1 to 3 days: Administrative issue or immediate scope mismatch.
• Rejection within 3 to 5 days: In-house + academic editor desk rejection per the 3 to 4 day initial decision.
• Still Under Review after 1 week: Strong signal. Paper passed the collaborative editor screen.
• Still Under Review after 8 weeks: Reviewer-recruitment or reviewer-report delay. A polite inquiry via the bench.benchpress.org portal is appropriate.
• Status changes to "Decision Pending": Reports are in; expect a decision within 1 week.

This is the most common anxiety we hear from JCB authors during the active editorial window. The honest answer: no, 4 weeks at Under Review puts you in the normal middle of JCB's post-screen review distribution. Reports may already be in editorial synthesis with the academic editor preparing the final decision in collaborative consultation with the in-house professional editor. Most reviewer-driven delays come from reviewer-recruitment timing for cell-biology subspecialty experts rather than slow reviews. If the portal still says Under Review at the 6-week mark, the most likely explanation is that one of the assigned reviewers asked for an extension and the academic editor granted it. This is normal practice at JCB.

What you should NOT do during the 4-to-6-week window is email the editorial office. JCB academic editors are working academics managing 30+ active papers around their own research; an inquiry at 4 weeks adds friction without accelerating the timeline.

If your JCB paper is rejected after review, the natural cascade depends on what the reviewers and academic editor cited:

Molecular Biology of the Cell (MBoC) is the natural ASCB cascade for cell-biology mechanism papers where the JCB priority bar is not met but the rigor is high.

Journal of Cell Science (JCS) is the Company of Biologists cascade for cell-biology research.

Cell Reports is the external Cell Press cascade for broader life-sciences work. Cell Press uses Editorial Manager at editorialmanager.com/cell-reports; editorial contact cellreports@cell.com.

Nature Cell Biology is the external Springer Nature cell-biology specialty cascade. The Nature Cell Biology Manuscript Tracking System at mts-ncb.nature.com handles submission; ncb@nature.com handles publisher-level inquiries.

Molecular Cell is the external Cell Press cascade for mechanism-depth molecular-biology cell-biology papers. Cell Press uses Editorial Manager at editorialmanager.com/molecular-cell; editorial contact molecular-cell@cell.com.

eLife is a cascade option for cell-biology work where the Reviewed Preprint model fits.

JCB asks reviewers to evaluate four things specifically. The table below maps each to actionable preparation.

This guide tells you what Journal of Cell Biology editors look for during the status window. Manusights has reviewed 50+ manuscripts targeting Journal of Cell Biology or adjacent cell-biology journals; full Manusights reviews include a 60-day money-back guarantee, and we do not train AI on customer manuscripts. Three recurring patterns separate strong JCB submissions from manuscripts that become difficult Under Review.

Manusights review data from this journal family shows a specific risk pattern: in practice, we see JCB editors and reviewers specifically look for image auditability and a broad cell-biology claim before they treat a visually strong figure set as JCB-ready.

Journal of Cell Biology manuscripts with narrow cell-biology framing in the abstract and first figure. The most common priority problem is not weak data. It is a manuscript that presents a pathway, cell type, perturbation, or imaging phenotype without making the general cell-biology principle visible. JCB editors can move quickly because they are asking whether the paper matters across the field, not whether the experiment is merely competent. The fix usually requires rewriting the title, abstract, introduction close, and first figure narrative so the reader sees the cellular mechanism, spatial organization principle, trafficking logic, organelle behavior, or quantitative cell-biological insight before the subfield details take over.

Check whether your JCB cell-biology framing clears the priority bar ->

Journal of Cell Biology manuscripts with image-data and quantification gaps. Many JCB-targeted papers look visually persuasive but are thin in the methods table, image-processing description, raw image trail, or quantification pipeline. The weak spot can be acquisition settings, exposure changes, contrast handling, segmentation rules, batch effects, replicate structure, or missing raw data availability. Because JCB's submission guidance puts responsibility on the corresponding author for data integrity and archiving, reviewers treat image auditability as part of the scientific claim. A strong package ties figure legends, methods, Supporting Information, raw data access, and controls into one readable evidence chain.

Check whether your JCB image-data package is reviewer-ready ->

Journal of Cell Biology manuscripts without single-revision discipline. JCB's single major-revision policy changes the meaning of Under Review. A manuscript can survive the first screen and still fail if the first response plan leaves major reviewer concerns unresolved. We see this most often when the authors treat reviewer comments as optional experiments rather than one coordinated revision package. Before the first decision arrives, build a response map against each figure, control, method, and data-availability issue so the revision can answer every material concern in one round.

Check whether your JCB single-revision response plan is complete ->

This page was created from Rockefeller University Press's public JCB editorial policies at rupress.org/jcb/pages/editorial-policies, JCB submission guidelines documentation (3 to 4 day initial decision target, in-house professional + academic editor collaborative consultation model, single round of major revision policy, 10-day decision after revision submission), JCB DataViewer image-data integrity documentation, and Manusights pre-submission review experience with JCB-targeted manuscripts. Source limitations: official guidance describes workflow mechanics, so the reviewer-risk guidance here is inferred from those sources plus Manusights manuscript-review patterns, not from private editorial records.

For the cell-biology landscape beyond JCB, see Molecular Biology of the Cell (ASCB cell-biology mechanism), Journal of Cell Science (Company of Biologists cell-biology research), Cell Reports (Cell Press broader life-sciences), Nature Cell Biology (Springer Nature cell-biology specialty), Molecular Cell (Cell Press mechanism-depth), and eLife (Reviewed Preprint cell-biology). The choice across these titles depends on whether the central contribution is top cell-biology priority (JCB), ASCB cell-biology mechanism (MBoC), Company of Biologists cell-biology research (JCS), Cell Press broader life-sciences (Cell Reports), Nature Portfolio cell-biology (Nature Cell Biology), Cell Press mechanism-depth (Molecular Cell), or Reviewed Preprint (eLife).

Reviewers at JCB typically draw from leading scientists active in the cell-biology subfield regardless of editorial board membership. Editors screen and triage manuscripts before any external reviewer sees them, and preparing a comprehensive revision response template that addresses every reviewer concern is essential given JCB's single-round major-revision policy.

For a pre-upload check of your manuscript against the JCB cell-biology-priority + image-integrity bar before submission, our JCB pre-submission diagnostic flags the framing and image-data weaknesses most likely to surface in reviewer reports.